News

01 Nov 2023

RTW Biotech Opportunities to acquire Arix Bioscience

RTW Biotech Opportunities (RTW) has announced that it will acquire Arix Bioscience. The transaction is expected to deliver RTW with an expected pro-forma net asset value of approximately $550 million, an increase of 63% The deal will enhance RTW’s profile, provide increased liquidity potential, a more efficient cost base, and a re-rating opportunity. Arix shareholders […]

01 Nov 2023
a green cup sits on a pile of books

QuotedData’s morning briefing 1 November 2023 – VEIL, BPCR, TLEI, THRL

In QuotedData’s morning briefing 1 November 2023: Vietnam Enterprise Investments Limited (VEIL) has announced that Mr. Gordon Lawson will step down as chair of the company and resign from the board, both effective 30 June 2024. Mr. Lawson has served as an independent non-executive director of VEIL since July 2014, and as chair since 2022. […]

31 Oct 2023

USF provides update on strategic review

US Solar Fund (USF) has provided an update on its previously announced strategic review. Having reviewed the available options as part of this strategic review, the company considered proposals in relation to: (i) a sale of its portfolio of assets and return of funds to shareholders; (ii) a sale of the entire issued, and to […]

31 Oct 2023

QuotedData’s morning briefing 31 October 2023 – OCI, CGT, RGL

In QuotedData’s morning briefing 31 October 2023: Oakley Capital (OCI), a leading pan-European, mid-market private equity investor, is pleased to announce that Oakley Capital Origin Fund I has agreed to acquire a majority stake in Alerce, a leading Spanish provider of transport and logistics software solutions. Origin will invest alongside Alerce’s founding family, including CEO […]

26 Oct 2023

Hipgnosis Songs Fund fails continuation vote

Following its AGM and EGM, the board of Hipgnosis Songs Fund announced that the company has failed to pass its continuation resolution.  As a result, the board will put forward proposals for the reconstruction, reorganisation or winding-up of the company to shareholders for their approval within the next six months. 71.5% of those voting opposed […]

25 Oct 2023

Realisations continue for Crystal Amber Fund

The Crystal Amber Fund (CRS) announced its final results for the year ended 30 June 2023. Net Asset Value per share decreased by 4.6% over the period while the company also returned £37.5m to shareholders, as it goes through the realisation of its assets, bringing total returns of capital to more than £100 million. At […]

25 Oct 2023

QuotedData’s morning briefing 25 October 2023 – NBMI, RCOI, ROOF, TMI

In QuotedData’s morning briefing 25 October 2023: NB Monthly Income Fund (NBMI), which is undergoing a managed wind down, has advised that it intends to distribute to shareholders an aggregate amount of approximately £23,537,000 by way of a partial compulsory redemption of shares on 13 November 2023. Pursuant to the compulsory redemption, the company will […]

24 Oct 2023

Outperformance in difficult year for VOF

VinaCapital Vietnam Opportunity Fund (VOF) announced its annual results for the period ended June 30, 2023. NAV total return in USD terms was -0.4% and the share price total return was -3.1%. While the VN Index is not a benchmark for the company, it serves as a useful comparison. Over the same 12-month period, the […]

24 Oct 2023

QuotedData’s morning briefing 24 October 2023 – GSF, SONG, PHP

In QuotedData’s morning briefing 24 October 2023: Following its recent strategic review, the board of Hipgnosis Songs Fund Limited (SONG) announced that it did not receive a superior offer as part of the Go-Shop process in connection with the first disposal. The company was in contact with 17 parties at the beginning of the Go-Shop, […]

18 Oct 2023

QuotedData’s morning briefing 18 October 2023 – NBMI, TOWN

In QuotedData’s morning briefing 18 October 2023: NB Global Monthly Income Fund (NBMI) provided an update for the month end September 30. The company noted that the managed wind-down of the portfolio, as described in the circular of 20 December 2022, has been in effect since the EGM shareholder approval of 27 January 2023. In […]